BSE Code :
NSE Symbol :
ISIN :
Industry :

Trade Now

Get Quotes

Open Price (₹)

Prev. Close (₹)

Volume (No’s)

Market Cap (₹)

Low Price (₹)

High Price (₹)

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
24-Jun-2021	NA	Trading Members of the Exchange are hereby informed that the under mentioned scrip code of the Company which has been suspended due to record date fixed for Corporate Action of Amalgamation shall be delisted with effect from June 24, 2021 (DR-059/2021-2022): Scrip Code 500676 ISIN No. INE264A01014 Name of the Company to be delisted GlaxoSmithkline Consumer Healthcare Ltd. Date of Suspension 16/04/2020 Reason Merged with Hindustan Unilever Ltd
17-Apr-2020	NA	Amalgamation
16-Apr-2020	NA	Sub: Suspension of trading in equity shares -GlaxoSmithKline Consumer Healthcare LimitedIn pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A,it is hereby notified that the following security will be suspended from trading w.e.f April 16, 2020 (i.e. closing hours of trading on April 15, 2020). Name of the Company GlaxoSmithKline Consumer Healthcare Limited Symbol GSKCONS Series EQ Reason for Suspension Scheme of Amalgamation This Circular shall be effective from April 16, 2020.For and on behalf ofNational Stock Exchange of India Limited
01-Apr-2020	NA	Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as per Form CAA 7 issued by the Hon''ble (NCLT), Chandigarh Bench on March 12, 2020 in respect of the scheme of amalgamation amongst GlaxoSmithKline Consumer Healthcare Limited and HUL and their respective shareholders and creditors under Section 230 to 232 of the Companies Act, 2013 ('Scheme'). In this regard, we wish to inform you that in accordance with the terms of the Scheme, a meeting of Board of Director of the Company is scheduled to be held on Wednesday, April 01, 2020, to take on record the sanction of the Scheme by Hon'ble NCLT Mumbai Bench and Chandigarh Bench and to declare the scheme effective. Further, it is to inform you that at this BM will consider the record date for the purpose of issuance of shares of HUL to the shareholders of the Company in accordance with the Scheme.
06-Feb-2020	NA	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Thursday, February 06, 2020 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Unaudited Financial Results for the Third Quarter ended December 31, 2019 with Limited Review by Auditors. We request you to take the above information on record. Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting Thursday, February 06, 2020 at 01:30 p.m. at Board Room, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122002 have, inter alia, considered and taken on record the Unaudited Financial Results for the Quarter ended December 31, 2019. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we wish to inform you that Mr. Vivek Anand resigned as Chief Financial Officer w.e.f. October 31, 2019 and Mr. Nitin Mathur joined as Head of Finance w.e.f. November 01, 2019. We are enclosing a copy of the Unaudited Financial Results for the Quarter ended December 31, 2019 along with the 'Limited Review' Report, issued by the Auditors for the review done by them, for your records. (As Per BSE Announcement dated on 06/02/2020)